未找到相关数据
Peginterferon alfa-2a (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBeAG-negative chronic hepatitis B:: 72-week results from a phase III, partially double-blind study of PEGASYS® alone vs PEGASYS® plus lamivudine vs lamivudine
被引：1
作者：
Marcellin, P
Lau, GKK
Bonino, F
Farci, P
Hadziyannis, S
Jin, R
Lu, ZM
Piratvisuth, T
Germanidis, G
Pluck, N
机构：
[1] Hop Beaujon, Serv Hepatol, INSERM, Unite 481, Clichy, France
[2] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China
[3] Osped Maggiore, Sci Direct, IRCCS, I-20122 Milan, Italy
[4] Univ Cagliari, Div Clin Med 1, Cagliari, Italy
[5] Henry Dunant Hosp, Dept Med & Hepatol, Athens, Greece
[6] Beijing You An Hosp, Digest Dis Dept, Beijing, Peoples R China
[7] Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
[8] Songklanakarin Hosp, Songkhla, Thailand
[9] Papageorgiou Gen Hosp, Pathol Clin, Thessaloniki, Greece
[10] Roche, Welwyn Garden City, England
[11] Hop Beaujon, Ctr Rech Claude Bernard Hepatitis Virales, Clichy, France
关键词：
D O I：
10.1016/S0168-8278(04)90095-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
95
引用
收藏
页码：34 / 34
页数：1
相关论文